Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis

Author： Gensicke Henrik   Leppert David   Yaldizli Özgür   Lindberg Raija L.P.   Mehling Matthias   Kappos Ludwig   Kuhle Jens  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.1, 2012-01, pp. : 11-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4858-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 17, Iss. 7, 2010-03 ,pp. : 640-650

Bentham Science Publishers

Access to resources Recommend Favorite

Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 12, Iss. 2, 2006-01 ,pp. : 241-249

Bentham Science Publishers

Access to resources Recommend Favorite

Treating multiple sclerosis with monoclonal antibodies: a 2013 update

By Deiß Annika   Brecht Isabel   Haarmann Axel   Buttmann Mathias  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 313-335

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-05 ,pp. : 134-143

Bentham Science Publishers

Access to resources Recommend Favorite